Cardiac antigen identified as mechanism for heart complication with immunotherapy-related myocarditis
Myocarditis is a complication that can occur in cancer patients treated with immune checkpoint inhibitors. Although the adverse event is rare — affecting less than 1% of patients given the immunotherapy — the mortality rate is nearly 50%. Now, researchers have identified the mechanism for the deadly heart inflammation.
Materials provided by Vanderbilt University Medical Center. Original written by Tom Wilemon. Note: Content may be edited for style and length.
Source link aaaaa